Extensive research indicates that bacteria colonizing tumors can significantly promote tumor growth, with the specific intratumoral microbiome inducing IL‐17 production, which subsequently promotes B cell recruitment and infiltration into tumor tissues, thereby triggering CRC progression. This evidence concerns the gene IL17A and neoplasm.